Lung cancer patients get second chance with combo therapy
NCT ID NCT05401786
First seen Mar 15, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This study tests whether giving a specific immunotherapy drug again, along with another drug and targeted radiation, can help control advanced non-small cell lung cancer. About 54 people whose cancer stopped responding to standard immunotherapy will receive this combination. The goal is to see if the treatment can shrink tumors or keep the cancer stable for at least 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Antoni van Leeuwenhoek - Netherlands Cancer Institute
Amsterdam, North Holland, 1066 CX, Netherlands
Conditions
Explore the condition pages connected to this study.